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ABSTRACT
Immunization has been used as an upstream, protective measure in public health for
decades. Although immunization programs have been introduced in Pakistan, new and
emerging infectious disease remains a concern in the country. The province of Sindh,
Pakistan is of special concern because of its large rural population.
The purpose of this study was to: 1) determine and compare complete and age-
appropriate immunization uptake in children 12 to 36 months and birth to 9 months,
respectively living in Sindh, Pakistan in 1994 and 1997; and 2) determine the correlates
of complete and age-appropriate immunization in children 12 to 36 months and birth to 9
months, respectively living in Sindh, Pakistan in 1997.
This study reviewed data that was collected as part of the School Nutrition Program
(SNP) and Family Health Project (FHP) in 1994 and 1997, respectively. Analyses
included immunization data on 1877 children from the SNP survey and 1694 children
from the FHP survey.
Females were found to have higher statistically significantly age-appropriate uptake than
males in 1997 (p=0.015). Complete immunization status was also found to vary
significantly by district of residence in 1994 and 1997 (p<0.001). Both complete and
age-appropriate immunization status was found to decrease from 1994 to 1997.
Multivariable logistic regression revealed that not owning a radio, electricity, or bicycle
was indicative of lower odds of complete immunization uptake (OR<1, p<0.05). Other
correlates predictive of lower odds of complete immunization included owning a water
pump (OR=0.360), not having a Lady Health Worker (LHW) visit the home
(OR=0.489), living in a kucha house (OR=0.637), and living in Tharparkar (OR=0.290),
Badin (OR=0.599), or Mirpur Khas (OR=0.271).
A similar regression analysis revealed child’s sex, ownership of a refrigerator, and
having heard of contraception to be correlates of age-appropriate immunization (p<0.05).
Females had higher odds of age-appropriate immunization (OR=1.851) compared to
males. Not having a refrigerator was indicative of lower odds (OR=0.079). Not having
heard of at least one type of contraception was a predictor age-appropriate immunization
(OR=1.925).
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INTRODUCTION
Immunization is the act of being exposed to an immunogen for the purpose of fortifying
the immune system against that immunogen. Immunization makes use of a killed form
of the virus that is unable to cause disease. Vaccination, a similar process, involves the
administration of a live, weakened virus, which can therefore potentially result in the
development of the disease. For decades, immunization and vaccination have been used
as an upstream, protective measure for protecting children, adolescents, adults and the
elderly against such infections and infectious diseases as polio, tuberculosis, diphtheria,
pertussis, tetanus, and the measles. Recent years have shown an increased interest in
such preventative measures; efforts are being made to reduce the overall incidence and
prevalence of these diseases worldwide.
1.1 The Pakistani Context
Pakistan is located in South-Asia and is home to roughly 155 million people (1).
Bordering on Iran, Afghanistan, China, India, and the Arabian Sea, its landmass is
approximately double the size of Canada’s Newfoundland and Labrador.
With little available potable water, recent natural disasters, and health indicators already
2mirroring those of other less-developed-countries (LDCs) (Appendix A), the fear of new
and emerging infectious disease in the country is great. The concern grows deeper when
examining the health of the country’s 60 million children (<15 years) (1). Protecting and
maintaining the health of these children is of utmost importance.
Within Pakistan, the province of Sindh is of special concern to researchers because it is
home to roughly 30 million people with 61% living in rural areas (2). As a result,
delivery and administration of immunizations is often difficult.
One of the four provinces of Pakistan, Sindh is both hot and humid. Within Sindh, the
districts of Thatta, Badin, and Mirpur Khas are arid. With no rivers or natural water
sources, potable water is in short supply. Residents of these districts often work in the
industry and service sectors. Although there is minimal rainfall, an extensive irrigation
system allows for agricultural production. The district of Tharparkar is also arid, but
differs from the other districts in terms of religion. Located in the south of Sindh, the
major religious group in Tharparkar is Hinduism. The absence of potable water in these
areas is often associated with poor nutrition and difficulty in treating disease.
One way of relieving the burden of disease is through national immunization programs.
The World Health Organization (WHO), which has helped in the planning and delivery
of such programs, maintains that “immunization is essential for children to achieve their
right to the highest attainable standard of health” (3). Tuberculosis, polio, measles,
diphtheria, tetanus, and pertussis are all currently listed on the recommended childhood
3immunization schedule for children in Pakistan (see Figure 1.1, below).
Figure 1.1 Pakistan's Childhood Immunization Schedule
Age (months)
Vaccine Birth 2 3 4 9
BCG Dose 1
Diphtheria,
tetanus, Dose 1 Dose 2 Dose 3
pertussis
MCV Dose 1
OPV Dose 1 Dose 2 Dose 3 Dose 4
*Immunization for Pakistan adapted from the World Health Organization (WHO) (1).
BCG = Bacillus of Calmette and Guerin MVC = Measles Containing Vaccine
DPT = Diphtheria Pertussis Tetanus OPV = Oral Polio Vaccine
1.2 Problem Statement
Historically, rural Pakistan has not been a major focus for researchers. The highly
populous rural communities are not easily accessed and services to these areas are not
immediately available. Research in Pakistan is therefore more often conducted in its
urban centres. These studies tend to use clinical-based data. There has been a resulting
need for population-based studies, especially in the rural districts. Without such studies,
it is difficult to gauge rural health in the country.
As there have been few studies conducted in rural Pakistan, very little has been done to
compare rural health across years. Many studies looking at health over time are, once
4again, largely clinical-based.
With the inception of the Global Polio Eradication Initiative, many questions were raised
as to the effect this program might have on the Expanded Programme on Immunization
(EPI). Some researchers hypothesized that by increasing their focus on the Oral Polio
Vaccine (OPV), all other immunization efforts would suffer; the administration of other
vaccines such as the Bacillus of Calmette and Guerin (BCG), Diphtheria Pertussis and
Tetanus (DPT) and the Measles Containing Vaccine (MCV) would drop, thereby
resulting in a subsequent increase in these diseases.
This study will make use of some of the hard-to-come-by rural population data, and, in
an attempt to address the aforementioned issues, will seek to compare immunization
uptakei across study years, with some focus on examining polio uptake.
1.3 Research Objectives and Study Questions
OBJECTIVE 1: To determine and compare complete and age-appropriate
immunization uptake in children up to three years living in Sindh, Pakistan.
1. What was the coverage of age-appropriate and complete immunization
among children aged birth to 9 and 12 to 36 months, respectively, in 1994
and 1997 in Sindh, Pakistan?
a. What was the immunization coverage of BCG, Polio, DPT, and
MCV in children in rural Pakistan in 1994?
i Uptake refers to the percentage of children from the study sample who have received the BCG, DPT, OPV, and MCV
immunizations; the terms coverage and uptake will henceforth be used interchangeably.
5b. How does this coverage compare to that in the same rural population
in 1997?
c. Do the rates vary from district to district?
d. Do the rates vary by sex of child?
OBJECTIVE 2: To determine the correlates of complete and age-appropriate
immunization in children up to three years living in Sindh, Pakistan in 1997.
2. What are the correlates (e.g. sex of child, parents’ education, district of
residence, socio-economic status, etc.) of complete and age-appropriate
immunization among children living in rural Pakistan?
1.4 Study Significance
Although Pakistan has proven to be in great need of research in the area of childhood
immunizations, very little has been done to accommodate this need. Moreover, there is a
growing interest in building capacity within the country to address these concerns (4).
This study will attempt to accommodate both of the aforementioned issues: it will aid in
bringing the issue of childhood immunizations to the attention of the research
community, while making use of data that was collected by knowledgeable local
researchers.
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LITERATURE REVIEW
This literature review seeks to provide an overview of immunization as it relates to
Pakistan and those diseases associated with this study: polio, tuberculosis, diphtheria,
pertussis, tetanus, and measles.
2.1 Health For All and the Eradication of Disease
Nineteen seventy eight was a landmark year for global health; it was then that the Alma
Ata Declaration on Health was made and the WHO and UNICEF took an unprecedented
stance in declaring Health for All by the year 2000 (5). The goal of this declaration was
not necessarily to eliminate disease, but rather to push for the equitable distribution of
health care resources among social and economical groups, and urban and rural
populations.
Since the declaration was made, many efforts have been aimed at increasing the
worldwide immunization of children. The WHO has been especially involved in the
disease eradication process – polio is one of their targets. In order to declare a disease
eradicated, the WHO has developed a certification process which must be done at the
local, national and global levels. Eradication status is obtained only after the number of
7incident cases remains zero for a minimum period of three years. It is believed that if no
new cases arise over this period, the population is then safe from the disease and it is
declared to be “eradicated” from that region, country, or continent.
2.2 The Need for Childhood Immunizations in Pakistan
In 1990, infectious diseases were responsible for over 55% of deaths among the world’s
global poor (6). In order for the LDCs that house the global poor to reach the levels of
the world’s global rich, an estimated 92.1% reduction in these deaths would need to
occur (6), most of which would be among children under 14 years. Through the use of
stringent immunization programs, this reduction may be possible.
In 1974, the WHO began the Expanded Programme on Immunization (EPI) in an effort
to fight tuberculosis, diphtheria, tetanus, pertussis, measles, and polio (7). The EPI
program began immunizing children in Pakistan on an experimental basis in 1978 (7, 8).
After preliminary results were analyzed, the program projected that over three million
cases and nearly 250,000 deaths would be prevented by 1990 (9). Indeed, the
introduction of the EPI program in Pakistan has resulted in a statistically significant
reduction of reported cases (see Figure 2.1). There is still, however, much that can be
done.
8Figure 2.1 Number of Reported Cases of Vaccine-Preventable Diseases in Pakistan
* Created using data from the World Health Organization’s (WHO) Immunization Profile of Pakistan (1).
Recent publications have listed Southeast Asia, for example, as having one of the
greatest populations at risk of developing tuberculosis (10). With deaths from this
disease numbering over one million people annually in Southeast Asia alone (10),
countries such as Pakistan are fighting an uphill battle in trying to keep this disease under
control.
In 1999, the WHO reported over 7,100 cases of polio worldwide, but expressed a fear
that many cases were misdiagnosed or underreported (11). Constant surveillance of this
preventable disease led the World Health Assembly to declare a Global Polio
Eradication Initiative in 1988; Pakistan joined the eradication efforts in 1994 (12).
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9While the disease still exists in the world today, these efforts have not gone unnoticed.
Primarily found in Africa, the Middle East, and South Asia, these efforts have shown a
significant decrease in overall rates. As of December 27, 2005, there were 1,719
identified global cases of polio; twenty-five of which were found in Pakistan (13).
Although polio was still recognized as being endemic to Pakistan in 2004 (Appendix B),
there were great hopes that the last case in Pakistan would be seen in 2005.
2.3 Poliomyelitis
First described in Egyptian carvings, poliomyelitis has exhibited its wrath against
humankind for centuries. In 1840, German orthopedist Jakob Heine was the first to
medically document this disease (14). Since then the disease, often referred to simply as
‘polio’, has played a historically important role in the understanding of infectious
diseases and the development of preventative and rehabilitative technologies (e.g.
immunization, the iron lung, orthopedic devices, reconstructive surgery).
Affecting primarily children and young adults, this highly infectious disease is spread
through direct person-to-person contact. The virus most often infects its new host
through the mouth as a result of fecally contaminated water or food. Caused by one of
three polioviruses, symptoms may range from headache, fever, sore throat, and muscle
stiffness, to paralysis of limbs, breathing difficulty, and death (15, 16, 17).
The first polio vaccine was discovered in 1950 by Hilary Koprowski. Although this oral
vaccine was never used in public health efforts because of safety concerns, it paved the
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way for the development of Dr. Jonas Salk’s injectable vaccine and Dr. Albert Sabin’s
oral vaccine – both of which were later used in immunization programs (16). To date,
there remains no cure for polio, although prevention measures are becoming more and
more effective.
In 2005, Pakistan reported 28 cases of polio (1). The WHO hopes to eradicate this
disease in the coming years, and has increased its immunization efforts accordingly.
2.4 Tuberculosis
Another disease of great historical significance is tuberculosis. The earliest evidence of
this disease has been found among the remains of Neanderthal skeletons and Egyptian
mummies.
Tuberculosis is first and foremost a disease of the lungs. The virus is spread through
direct human-to-human contact and manifests itself within the host by means of airborne
droplets (from a cough, sneeze, etc.). The virus multiplies in the lungs and if the initial
immune response fails to stop the spread, the central nervous system (CNS), lymphatic
system, circulatory system, bones, and joints may also be affected.
Symptoms may include loss of energy, poor appetite, and listlessness (16). Severe
coughing and the expectoration of sputum do not appear until months after the initial
infection. Since the earlier symptoms are not unique to tuberculosis, diagnosis may be
confirmed with the Manatoux skin test.
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The tuberculosis vaccine, also known as the Bacillus of Calmette and Guerin, or BCG
vaccine, was first developed in 1921 at the Paris Pasteur Institute by Albert Calmette and
Camille Guerin, two French bacteriologists. The vaccine, which is not recommended for
immuno-compromised individuals, is prepared from weakened bovine tuberculosis
bacillus (16). Since its inception, over 100 million people have been vaccinated against
tuberculosis using the BCG vaccine.
Developed countries are currently exhibiting such a low incidence of the disease (rates
less than 1% per year) that use of this vaccine for childhood immunization is no longer
recommended. The vaccine continues to be used, however, among professionals who
are at risk of prolonged exposure (e.g. nurses) and individuals in LDCs where
tuberculosis remains a health concern.
2.5 Diphtheria, Pertussis, and Tetanus
The DPT vaccine is a multipurpose vaccine, protecting against diphtheria, pertussis and
tetanus.
Diphtheria is a bacterial disease that may take on an inhalational or cutaneous form. It is
highly contagious and is transmitted from person-to-person; it may be carried in the
mouth, nose, throat, or skin. Symptoms may include headache, fever, and sore throat,
and may lead to difficulty breathing. Diagnosis may be confirmed by identifying the
causal agent from a throat swab. The first diphtheria antitoxin was developed in the
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1890s by Emil von Behring in Germany (18). This antitoxin, although not effective in
killing the bacteria, was able to neutralize the toxins produced by the bacteria through the
process of immunization. If contracted, diphtheria is now treated with antitoxins and
bactericidal drugs (e.g. penicillin). Pakistan reported 23 cases of diphtheria to the WHO
in 2005 (1).
Pertussis is more commonly known as the ‘whooping cough’, named for its
characteristic ‘whoop’. Symptoms include coryza and a persistent (and sometimes
violent) cough. Afflicting primarily children under the age of one, roughly 90 percent of
cases worldwide occur in LDCs (17, 19). The bacterium Bordetella pertussis is
transmitted from person-to-person through airborne droplets. The first whole-cell
pertussis vaccine was developed in 1926 by Louis W. Sauer in the United States (19).
Acellular vaccines have since been developed which result in milder side effects. The
WHO received 133 reports of pertussis in Pakistan in 2005 (1).
Tetanus is a highly fatal yet ultimately preventable, non-contagious disease that results
when the Clostridium tetani bacterium secrets the tetanospasmin neurotoxin. First
documented circa 5 B.C., the disease was not properly understood until Carle and
Rattone discovered its etiology in 1884 (19). The bacterium, which may be found in
agricultural soil and in the feces of a variety of farm animals, infects its host through
breaks in the skin. Tetanus is more commonly known as lockjaw because this noticeable
symptom is often seen among infected individuals. Other symptoms may include, but
are not limited to: stiffness in the neck and back, risus sardonicus, difficulty swallowing,
13
muscle rigidity in the abdomen, fever, and diaphoresis. The disease is virtually unseen
in immunized individuals. WHO reports indicate 697 cases of tetanus in Pakistan in
2005 (1).
The first DPT vaccine was developed in the 1930s and had a whole-cell pertussis
component. The newer “mixed vaccine of formalin-inactivated diphtheria, tetanus
toxoids, and pertussis vaccine” (16) now contains an acellular pertussis component.
These two vaccines are often referred to as DTwP and DTaP, respectively.
2.6 Measles
The measles is a contagious disease that was once confused with smallpox. Important
differences between the two were described by Ibn Al-Razi, a Persian physician, in the
10th century (16). The measles virus is spread directly from person-to-person by
airborne droplets. It is known to be highly contagious, infecting 90% of people (without
immunity) who come into close contact with the infected person.
Symptoms may include fever, cough, coryza, conjunctivitis, Koplik’s spots inside the
mouth, a rash (which may itch) starting along the hairline and spreading over most of the
body (16, 17). With an incubation period of 10-12 days (in which the patient is
asymptomatic), the infected individual remains contagious until after the rash appears
(15). No treatment (other than bed rest) is available for the measles.
The measles-containing vaccine (MCV) was available for use by 1963 (16). Despite the
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uncommon existence of measles in more developed nations, it remains a health concern
in LDCs (3). WHO statistics indicate that in Canada, for example, there were six
reported cases of measles in 2005 (1). Over the same time period in Pakistan, however,
2,981 cases were reported (1).
2.7 Study Designs and Immunization Status: An Overview
A solid design and sound methodology is necessary for any good study. With respect to
the collection of immunization data, four particular approaches are discussed in the
literature: the EPI cluster survey, the systematic survey, Lot Quality Assessment
Sampling (LQAS), and the review of medical charts.
First is the population-based EPI sampling design. The typical cluster survey seeking to
assess immunization status requires that data from 30 clusters of 7 households (30 x 7)
be collected (20, 21). This study design is often tedious and requires more time and
effort to complete, compared to other methods. This design has been validated for the
use of assessing immunization uptake. Even so, there is a possibility of running into
certain design effect problems. This design, for example, is not suitable for collecting
data on the prevalence of infectious diseases, as the diseases themselves often occur in
clusters, and prevalence is likely to be over- or underestimated (21). The same weakness
may be seen if immunization efforts are particularly high or low in a particular region.
Additionally, population size cannot be estimated. Finally, although the original 30 x 7
cluster design cannot be used to present the correlates of immunization, this may be
achieved with some slight modifications to the methodology.
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Another study design that has been shown to yield comparable results in estimating
immunization uptake (21) is the systematic survey. This design differs from the cluster
survey in that households are selected through the use of a fixed sampling interval, and
that interviewers move systematically through the sample area, collecting data from all
streets in the entire zone. This method allows for the estimation of population size, and
has been argued to provide a more representative sample than that achieved in the cluster
survey (21). Unfortunately, the systematic nature of this methodology becomes
somewhat less systematic when surveying areas where streets are not clearly defined.
As a result, cluster surveys often become the method of choice when exploring rural
areas.
A third study design often used to measure immunization uptake is the Lot Quality
Assurance Sampling (LQAS). Originating from the manufacturing industry, this type of
methodology seeks to determine acceptable immunization coverage of a town, for
instance, based on the sampling of only a few townspeople (22). Sample size and
quality assurance decisions vary from study to study, and the researcher must carefully
weigh the possibility of making Type I and Type II errors while making such decisions.
This methodology, while not suitable for ascertaining correlates of immunization, is
adequate for determining whether or not the sample area is under-serviced with regards
to immunization efforts.
One final method for assessing immunization coverage is the review of medical and
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administrative data. First, medical charts, while often used as a source of information in
more affluent nations, are not appropriate for research in the context of LDCs.
Especially in the realm of rural health, medical charts are often unavailable. The use of
administrative data therefore becomes more appealing. By simply dividing the number
of administered doses by the number of eligible children, immunization coverage may be
estimated (23). As with the LQAS, however, this method is of only real use when
assessing uptake; correlates of immunization cannot be assessed. The modified cluster
survey method therefore reemerges as the design most suited to measuring uptake and
the independent variables associated with it.
2.8 Assessing Immunization Status: Validity and Reliability of Parental Recall
Typically when a child receives their first set of immunizations, the doctor provides the
child’s parents with an immunization card – a chart for which all future immunizations
can be recorded on. In many cases, however, this record is often lost or misplaced. For
low-income families, this paper may mean they can start a fire in the winter time, or use
it as scrap paper. When it comes time to report on their child’s past immunizations,
parents must often report the event from memory.
Many studies have been done to assess the validity and magnitude of recall bias in the
reporting of immunization status. In 2002, a Scottish study was published about parental
recall of measles mumps rubella (MMR) vaccination in their children (24). A survey
was administered to the parents of 171 reportedly unvaccinated children (according to
medical charts), and the percent agreement between records and recall was assessed.
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The authors found that many parents of the unvaccinated children believed that they had,
in fact, been vaccinated (24). Immunization based on parental recall is often
overestimated (25). A separate study in India sought to measure recall bias in the
estimation of immunization coverage of 774 children. Parents were asked to report on
the status of their child’s DPT, OPV, BCG, and measles immunizations. Fewer than
50% of mothers reported having kept the immunization cards. For those cards that were
available, over 70% were incomplete. Sensitivity and specificity of recall was reported
to be 41.3% and 79.5%, respectively (26). The respondent’s (mother’s) age was
correlated with degree of bias. Although this particular study found the sensitivity to be
lower than ideal, a more recent study concluded that parental recall is more sensitive than
data from immunization cards in retrospective studies (27). The authors advised that
recall be “accepted as reasonably reliable in the absence of cards” (27).
2.9 Defining Immunization Status
When assessing immunization status, the sensitivity and specificity of parental recall
have been shown to present problems in obtaining valid, dose-specific data. As a result,
more general reporting measures have been adopted in the literature. Rather than
reporting immunization status for each dose, studies often report a child’s immunization
status as being “complete”, “partial”, or “age-appropriate”. These methods may be more
likely to reduce the biases inherent in cases of recall. Moreover, the information may be
more relevant and appropriate to the study questions and analysis. An infant, for
example, who has had his first round of immunizations, would be more appropriately
categorized as “age-appropriate” immunization attained, rather than immunization
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“incomplete”.
When assessing immunization status, international organizations such as the WHO and
UNICEF use complete and age-appropriate categorizations. Using the WHO/UNICEF
Joint Reporting methods, complete or full immunization is defined as all children aged
12 to 36 months who have received all recommended doses (BCG, DPT3, OPV3, MCV)
of immunization. The same Joint Reporting format defines age-appropriate or infant
immunization as children under 12 months who have received BCG, DPT, OPV and
MCV doses appropriate to their age in months (28).
2.10 Benefits, Barriers and Risk Factors Affecting Immunization Uptake
Recent studies have recognized such things as religion, education, place of residence,
number of children in the household, employment status of the parents, and distance to
the nearest health facility to all be predictors of immunization (29, 30, 31, 32). Lack of
time and motivation on behalf of the parent, and unavailability of a vaccine at the closest
facility have been identified as being potential barriers to childhood immunization (7,
29).
2.10.1 Andersen’s Model of Determinants of Healthcare Use
In the early 1970’s, Ronald Andersen created a framework for the study of access to
healthcare services (33). This framework has been widely used to explain the use of an
array of healthcare services, including immunization availability and uptake. Although
the model has been modified over the years, three general principles embedded in the
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framework have remained constant over time: predisposing factors (i.e. age, sex,
education level, health beliefs), enabling factors (i.e. income, insurance, regular sources
of care), and need (34). Each of these three principles helps describe the characteristics
of the population at risk and the likelihood that they will seek care.
In 2005, Acosta-Ramírez et al. (35) modified Andersen’s Behavioural Model of Health
Services Utilization to explore the determinants of immunizations in Colombia (Figure
2.2). Although the motives were somewhat political in nature, the principles used may
be applied to this study of immunizations in Pakistan. The researchers used a cross-
sectional study design, administering surveys across the city of Bogotá. They sampled
notably poor localities. Dependent variables relating to predisposing factors, family
characteristics, enabling factors, need, and knowledge and satisfaction of the
immunization services were collected. Independent variables relating to health care
system characteristics (i.e. public versus private services, distance to provider, wait
times) were also collected. The following variables were associated with increased
likelihood of immunization: belonging to a family of eight or more people, living in the
East Central or South district, and having a head of house whose education amounted to
four years or less (35). Knowing and understanding the immunization requirements was
also a statistically significant predictor of uptake (35). As mainly poor localities were
assessed, household income and socio-economic status (SES) was not found to be
statistically significant in predicting immunization status. Many of these findings,
especially those of family size, parental education and SES, are contrary to other studies
that have sought to explore the determinants of immunization uptake.
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Figure 2.2 Adapted Version of Andersen’s Behavioural Model of Health Services
Utilization
SOURCE: Acosta-Ramirez et al., 2005 (35).
Other studies have found such things as large family size, low SES, and fear to be
predictive of low immunization rates (36). In having a large number of children, it
becomes a problem bringing them all along into town, and may be a hassle to
alternatively find someone to watch the children for the day. It may also be problematic
and not economically feasible to take a day off work to have their child immunized.
A recent evaluation of the EPI vaccination program in Nepal, for example, found
coverage levels to be approximately at or above herd immunity levels (30). The same
study examined the effect of parental education as a determinant of childhood
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immunization status. As the parent’s education level increased, so too did the children’s
level of immunization (non-immunized, partial or complete) (30). Similarly, a 1992
study in India on immunization coverage demonstrated overwhelming evidence that by
providing parents with educational materials on health, nutrition, and the importance of
childhood immunization, immunization rates would jump to nearly three times the rates
of the control group; the greatest increase was noted among the urban population (37).
When speaking to the role of SES in immunization uptake, most studies find that a low
SES is indicative of lower uptake levels. Despite these often overwhelming findings,
there are studies scattered throughout the literature that show the reverse effect of SES
on immunization uptake. One study, for example, sought to explore the relationship
between economic status and immunization uptake in children aged 19 to 35 months,
residing in the United States (38). Using data from the 2003 National Immunization
Survey (NIS), SES, among other demographic variables, was assessed. The researchers
found that, unlike so many other studies, low SES was associated with high uptake levels
(38). One potential explanation of this finding relates to the location of study. The
United States, being a more affluent nation, has undoubtedly more resources and better
coverage for their immunization efforts. LDCs lacking these resources tend to find that
the opposite is true. Recent studies in India (39), Bangladesh (40), and Turkey (41), for
example, all found that low SES was associated with poor uptake levels. In India, SES
was determined by income levels. Low SES was found to be a predictor of low
immunization coverage in both urban and rural populations (39). This trend was evident
when stratifying by sex and was apparent in both study periods: 1992-3 and 1998-9. In
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Bangladesh, food security status was used as a measure of economic status. Researchers
found that children living in households with a food surplus reported almost 50% higher
immunization uptake levels than children residing in food deficit households (40). The
Turkish study found that the odds of children with a high SES background being fully
immunized were 2.41 times the odds of children from low SES backgrounds (95% CI=
1.034, 1.657) (41). It is expected that the data from this Pakistan study will reflect the
findings of other LDCs, as presented, above.
One final predisposing factor in the Andersen model that has not yet been discussed is
gender. Much research has been done in the way of gender and immunization. In most
studies examining correlates of immunization, sex of the child is often the first thing
discussed. Although some studies have found that gender is not a statistically significant
predictor of uptake, the general consensus among researchers is that if a difference is
found, it is that males are more likely to be fully-immunized than females (42).
One study of children in India reported full immunization in terms of the gender gap,
stratifying for SES and rural or urban residences (39). The results were overwhelming.
In 1999, rural residents at all levels of SES combined showed a 2.81% gap in
immunization uptake across sexes, with males being more likely to be fully-immunized
(39). While this may not sound large, statistical analyses revealed that the gap was
statistically significant at p<0.01 (39). The gender gap among urban residents was even
larger at 4.03%, p<0.01 (39). The same study revealed that overall, the gender gaps in
both rural and urban areas have increased from 1993 to 1999 (39).
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2.10.2 The Health Belief Model
Another framework that has been useful in explaining health-seeking behaviour is that of
the Health Belief Model (HBM) (43). This psychological model states that health
behaviours are a function of three main factors: individual perceptions, modifying
factors, and likelihood of action. The HBM has been used to explain preventative health
behaviours, and may be applied to the topic of immunization.
In order for someone to seek preventative medicine, individuals must:
1. believe that the negative health outcome (e.g. measles, polio, tetanus) is a
perceived threat and that it may be prevented;
2. expect that by taking preventative measures (i.e. being immunized) that the
negative health outcome will be avoided;
3. feel comfortable and confident in the treatment regime (i.e. immunization); feel
that the benefits will outweigh any potential negative outcomes (44).
To this end, parental beliefs play a large role in whether or not their children are
immunized. Failure to recognize any of the above criteria will decrease the likelihood of
immunization uptake. Furthermore, parents showing fears of needles (36), fear of side
effects, or lack of comfort with Western medicine (45) may also cause them to shy away
from seeking routine immunization for their children.
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2.10.3 The Rural Context
Located in southeast Pakistan, Sindh is a relatively rural area of the country and has most
of its inhabitants living in rural and remote areas. Studies have shown that rural areas are
more likely to have more un-immunized children and fewer fully-immunized children
than urban populations (29, 39, 40, 46). Often, this discrepancy is due to such factors as:
a lack of transportation to the nearest health centre, inadequate funds to pay for travel,
inability to travel due to poor road conditions, and the inability of a parent to leave some
children at home while bringing others to be immunized. These factors have long been
identified as being potential barriers to immunization that are specific to rural
populations. Immunization efforts have therefore recognized the need to offer door-to-
door or village visits in such areas in order to reach the more remote communities (12).
2.11 Gaps in the Literature
Through the analysis of the literature, it has become apparent that there are certain gaps
that are not being addressed. First and foremost, it is obvious that Pakistan – especially
rural Pakistan – is not a focus in the literature. When doing a Medline (OVID) online
search, combining the terms “Pakistan” and “immunization” reveal only five articles.
Moreover, two of these articles focus only on Karachi, a large urban centre. None of the
articles deal specifically with rural populations. None of the articles speak exclusively of
the use and uptake of BCG, OPV, DPT, or MCV.
Additionally, the data that is currently available regarding immunizations is often clinical
in nature. Counts taken from immunization programs is one common way of assessing
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immunization status. Very few studies, however, use an on-the-ground population-based
approach. While cluster survey designs offer some relief to the problem, there are, as
mentioned previously, many generalizations made when using this technique, which
make the exact determination of correlates difficult.
This study, will address each of these gaps. While using population-based survey results
from rural Pakistan, an effort will be made to assess the immunization uptake of diseases
that – although not prevalent in more affluent countries – still plague less-developed-
countries like Pakistan.
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CHAPTER 3
METHODOLOGY
Data for this study were collected as part of two cross-sectional studies in Sindh,
Pakistan: 1) in 1994 through the School Nutrition Program (SNP) and; 2) in 1997 as part
of the Family Health Project (FHP).
3.1 Sample
Data was collected in Sindh, Pakistan – one of the country’s four provinces. Sindh is
administratively divided into 18 districts. Immunization data from the SNP and FHP
surveys were available from four of these districts: Thatta, Tharparkar, Badin, and
Mirpur Khas. All families residing in these districts were potential survey participants.
Assuming a confidence level of 95%, it was estimated that 2000 children were needed to
obtain an adequate study sample. Data were collected until the appropriate study sample
was achieved. SNP and FHP collected immunization data on 1877 and 1694 children,
respectively. A summary of sample size collected in each district is shown, below
(Table 3.1).
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Table 3.1 Summary of data collected
Thatta Tharparkar Badin Mirpur Khas
School Nutrition Program (1877) 415 (22.1) 522 (27.8) 480 (25.6) 460 (24.5)
Family Health Project (1694) 449 (26.5) 412 (24.3) 429 (25.3) 404 (23.9)
Study (n) District, n (%)
3.2 Method
Funded by the Norwegian Agency for International Development and the World Bank,
the SNP project sought to address the issues of illiteracy and malnutrition in Thatta,
Tharparkar, Badin, and Mirpur Khas. By contrast, the FHP project sought to strengthen
the existing public health system by: increasing child and maternal health, reducing the
incidence of infectious disease, and providing an opportunity for increased capacity
building and inter-institutional collaboration. This project was also funded by the World
Bank.
3.2.1 Data Collection Procedures
The immunization status of children (< 3 years) was collected as part of the baseline
surveys for both SNP and FHP (see APPENDIX C and D). These cross-sectional
studies employed the use of a stratified random sampling, whereby each district was
divided into strata (villages) and simple random samples (households) were selected
from within each stratum.
The proportion to population size (PPS) technique was used to select households for the
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study. Prior to the selection of individual households, a population profile of the study
districts was completed. For each participating village, the total number of households
was counted. The number of households subsequently surveyed from each village was
proportionate to the size of that village. More households were selected from larger
villages than from smaller ones.
Following the population profile, the selection of households continued with the creation
of a map of each participating village. Important landmarks were included (e.g. church,
store, school); one was subsequently chosen, at random, to serve as the starting point. At
the selected landmark, a bottle was spun. After coming to a stop, the mouth of the bottle
indicated the direction in which researchers would proceed. Researchers visited the first
house they came upon. Subsequent houses were chosen based on proximity (that is, the
second house visited was that which was closest to the first, the third house was that
which was closest to the second, etc.). This process was repeated until the household
study sample was met for that stratum.
All surveys were administered by trained interviewers. The term “trained interviewers”
refers to a selected group of females with grade 10 education who were recruited from
the community for the purpose of these studies. Prospective interviewers attended three
days of training workshops. Those who successfully completed this training became
certified interviewers for the studies. Inter-rater reliability was monitored by Masters-
level social scientists through the supervision of interviews.
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For each household, the mother or guardian provided verbal consent to the survey. In
the event that the mother or guardian was not available, two further attempts were made
to contact them. In each household, all children three years and under were included in
the survey. Since many birth certificates were not available, age was estimated
according to relevant local events.
Where available, the child’s immunization status for each of eight shots (1 BCG, 3 OPV,
3 DPT, 1 Measles) was determined based on their immunization card. In cases where
the immunization record was not available, immunization status was assessed based on
the mother’s recall.
In addition to immunization information, data on many socio-demographic variables
were also collected. Such variables include household economic status (based on
monthly income, type and size of house, material possessions), and education and
health-seeking behaviour of the mother (i.e. use of breast-feeding, oral rehydration
solution, utilization of health care services).
3.2.2 Data Sources
Both SNP and FHP datasets were accessed through the principal investigator, Dr Syed
Shah. The datasets were shared following ethics approval for the project.
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3.2.3 Ethics and Measures of Confidentiality
Data were stored in locked filing cabinets and secure computer files. Original survey
responses were not available. All identifying information was removed from the data;
subjects were coded using household and personal identifiers. Only aggregate data were
reported.
Prior to analysis, ethics approval was sought from the Biomedical Science Research
Ethics Board at the University of Saskatchewan. On April 26, 2006, this work was
deemed exempt from approval due to the de-identified nature of the data (see Appendix
E).
3.3 Study Variables
Immunization status was the outcome variable of interest. Independent variables
included measures of socio-economic status, sex of child, and district of residence.
3.3.1 Dependent Variables: Defining Immunization Status
The SNP and FHP surveys collected immunization information on eight vaccines: BCG,
OPV1, OPV2, OPV3, DPT1, DPT2, DPT3, and MCV. Using the survey responses
“yes”, “no”, and “don’t know”, the variables were dichotomized into simple “yes” or
“no” answers. Using these responses, complete and age-appropriate immunization status
was derived. Immunization status was coded according to current definitions, as
recognized in the literature and as used by such international organizations as UNICEF
and the WHO. A summary of these definitions is presented in Table 3.2.
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Table 3.2 Defining Immunization Status
Age-Appropriate or
Up-to-Date
birth - 9 months
Not Age-Appropriate or
Not Up-to-Date
birth - 9 months
Complete 12 - 36 months
Incomplete 12 - 36 months
Number of children who are missing one or more
recommended doses for their age.
Number of children who have received all of the
recommended doses of BCG, OPV, DPT and measles.
Child AgeTerm Definition
Number of children who have received all
recommended doses for their age. Specifically, birth - 2
months having BCG; 3 - 5 months having BCG, OPV1,
DPT1; 6 - 8 months having BCG, OPV3, DPT3; and 9
months having BCG, OPV3, DPT3 and measles.
Number of children who are missing one or more doses
of BCG, OPV, DPT and/or measles.
The majority of the analysis uses these dichotomized immunization data as the
dependent variables. These outcome variables refer to “Vaccination Service Use” in the
modified conceptual model discussed in Chapter 2 (35).
3.3.2 Independent Variables
Not all survey variables were available for analysis. As a result, most of the remaining
independent variables were used, where appropriate.
For the first part of the analysis – comparing immunization uptake across study years –
three independent variables were used as a means of comparison: sex of child, age of
child, and district of residence. The subsequent analysis of correlates used the
independent variables listed in Appendix F. Most variables were coded in categorical
form. Where appropriate, independent variables were dichotomized. Each of these
independent variables fits under “Population Characteristics” in the conceptual model
discussed in Chapter 2 (35).
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3.4 Data Management and Analysis
Data analysis was completed using SPSS 14.0 statistical software.
3.4.1 Data Cleaning
Prior to analysis, the data required much attention with regards to cleaning. The SNP
dataset came with no labels or variable coding information. Much time and effort was
spent assuring the variables were coded correctly. Where doubt existed, it was
recommended that the analyses of previously published papers using the dataset be re-
run (47, 48). In doing so, the variables could be coded in accord with prior work on the
dataset. After coding and labeling the variables, some inconsistencies were found in the
data (e.g. two variables coding child age, showing different distributions). When such
inconsistencies were encountered, advice from the principal investigator was sought.
With this SNP dataset, it was also found that not all children possessed a unique
household identifier. That is, there were multiple children per household. Since this
dataset was not to be used in the multivariable analysis of correlates of immunization,
none of the children was excluded from the analysis.
The FHP dataset presented similar problems. Without a proper code book, labeling and
coding variables had to be done very carefully, consulting with the study’s primary
investigator. With regards to immunization, the FHP data contained questions about
nine potential shots – one more than that in the SNP data. Since the time of the SNP
survey, an inoculation of OPV at birth was introduced in Pakistan, bringing the OPV
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shots up to four. Upon running a preliminary descriptive analysis, however, it was found
that the status of this OPV shot was only available in one of the four districts surveyed
(i.e. Mirpur Khas). Using this in the definition of complete/incomplete and age
appropriate immunization status meant that the results were being skewed strongly
toward incomplete or not up-to-date. As a result, it was decided to omit the OPV at birth
shot from the FHP analysis.
3.4.2 Descriptive Analyses
A descriptive analysis on immunization status was conducted for both (1994 SNP and
1997 FHP) datasets. The data were broken down by sex of child and district of
residence for each survey. Cross tabs and Pearson’s chi-square significance levels were
reported. This allowed for a general reporting of how the data were distributed.
3.4.3 Research Objective 1: Immunization Uptake in 1994 and 1997
Comparison of immunization uptake across study years was conducted. This analysis
began by comparing the uptake of each of eight vaccines (BCG, OPV1, OPV2, OPV3,
DPT1, DPT2, DPT3, and MCV) in males and females across study years. Cross tabs
were done and Pearson’s chi-square significance levels reported.
Complete and age-appropriate immunization uptake was subsequently analyzed. Using
the dichotomized immunization data, cross tabs and Pearson’s chi-square values were
reported with specific attention to uptake between sexes and districts.
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Using the complete and age-appropriate data, trends in immunization uptake across years
were noted. Again, specific focus was put on uptake between sexes and districts.
3.4.4 Research Objective 2: Analysis of Correlates
Logistic regression is a widely accepted and used method of determining which
independent variables are statistically significant predictors of a dependent variable’s
outcome. Hosmer and Lemeshow (49) are often referenced for their comprehensive
look at how to use regression models; a modified computer-driven version of their
methods is used here.
Since each of the children in the FHP dataset contained a unique household identifier,
and the outcome variable was dichotomous, it was decided that logistic regression was
an appropriate form of multivariable analysis to determine correlates of immunization.
Four major steps were taken in this stage of the analysis.
STEP 1: Bivariate analyses were carried out using the FHP data. These analyses were
done to evaluate each survey variable for its unadjusted association with complete and
age-appropriate immunization status. Independent variables with a p-value <0.20 in the
bivariate analysis were to be included in the multivariable logistic regression models.
STEP 2: Identifying independent variables to use in the multivariable analyses. Since
there were a number of statistically significant SES-related variables, there was some
concern that some had the same distribution as others, thereby demonstrating
35
collinearity. In an effort to reduce the number of SES variables entered in the
multivariable model, tests were done to ensure the distributions were different. A series
of 2 x 2 tables were created in order to assess the similarities of distribution; chi-square
and significance values were assessed. In the event that no statistically significant
difference was observed, only one of the two variables was chosen for the multivariable
model.
STEP 3: Model building was used to determine which correlates were statistically
significantly in affecting immunization outcome; the forward selection option was used.
Two models were created during this step of the analysis, using independent variables
from step 1 (p<0.20). The first was created to assess the correlates of complete
immunization in children aged 12 to 36 months. The second model was to assess the
correlates of age-appropriate immunization in children birth to nine months.
STEP 4: In this fourth and final step, Hosmer’s Goodness of Fit test was conducted. In
this step, the null hypothesis being tested is: the model adequately fits the data. If the
null hypothesis is rejected, the model should be re-examined. By contrast, if the null
hypothesis is not rejected, the model is deemed to adequately fit the data.
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CHAPTER 4
RESULTS
4.1 Characteristics of Study Subjects
Since the initial focus of the SNP and FHP surveys was to increase health, many socio-
demographic variables were collected, but only a limited number of the collected
variables revealed personal demographic or predisposing information about the study
children. Age and sex are two of these variables.
The following figures show the breakdown of males and females by survey year and
health district (Figures 4.1 and 4.2). The results reveal a relatively equal distribution of
males and females within each district. No statistically significant difference was found
between sexes (Pearson Chi-Square=3.298, df=3, p=0.348) in the SNP data. Similarly,
the FHP data showed no statistically significant difference in sex across districts
(Pearson Chi-Square=2.336, df=3, p=0.506).
37
Figure 4.1 Child’s sex by District, 1994 SNP Survey
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Figure 4.2 Child’s sex by District, 1997 FHP Survey
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Age of the children was an important variable in determining immunization status.
Below is a summary of the study children’s ages by survey year and district (Table 4.1,
Table 4.2).
Table 4.1 Child Age by District, 1994 SNP Survey
Thatta Tharparkar Badin Mirpur Khas
Child Age 415 (100.0) 522 (100.0) 480 (100.0) 460 (100.0)
0-11 months 115 (27.7) 155 (29.7) 144 (30.0) 152 (33.0)
12-23 months 114 (27.5) 149 (28.5) 123 (25.6) 124 (27.0)
24-36 months 186 (44.8) 218 (41.8) 213 (44.4) 184 (40.0)
Independent Variable District, n (%)
Table 4.2 Child Age by District, 1997 FHP Survey
Thatta Tharparkar Badin Mirpur Khas
Child Age 449 (100) 412 (100) 429 (100) 404 (100)
0-11 months 137 (30.5) 169 (41.0) 65 (15.2) 151 (37.4)
12-23 months 116 (25.8) 119 (28.9) 61 (14.2) 121 (29.9)
24-36 months 196 (43.7) 124 (30.1) 303 (70.6) 132 (32.7)
Independent Variable District, n (%)
As noted in tables 4.2 and 4.2, the majority of the children fall into the 24 to 36 month
age category; much fewer children are under 12 months of age. This will result in a
large sample size in the analysis of complete immunization, and a smaller sample for
age-appropriate immunization.
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4.2 Research Objective 1: Immunization Uptake in 1994 and 1997
Immunization status was assessed based on the survey responses for each of the eight
vaccines. Survey responses for all children and districts are summarized in Table 4.3.
As expected, the number of children who have received OPV and DPT immunizations
decreases with each successive dose in both males and females. Fewer females are
shown to have been immunized than males for each of the eight immunizations in 1994
(approximately 2% less in SNP). The FHP data, however, reveals slightly different
trends. In 1997, females and males appear to have been immunized nearly equally for
many of the recommended doses (BCG, OPV1, DPT2). For the doses of OPV2, OPV3,
DPT3, and MCV, uptake in males is only slightly higher than in females (approximately
1%). Moreover, in the dose of DPT1, females actually show a slightly higher uptake
than that of their male counterparts (41.4% females versus 39.2% in males). The
equalization of immunization uptake across sexes from 1994 to 1997 was expected.
The uptake of each vaccine was compared across sexes in a series of two-by-two tables.
Although some differences in sex are observed, none of these differences was found to
be statistically significant (p>0.05) (Table 4.3).
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Table 4.3 Vaccine Coverage Among Children birth to 36 months in Sindh, Pakistan 1994 and 1997
Yes No Yes No Yes No Yes No
BCG 679 (72.6) 256 (27.4) 588 (70.1) 251 (29.9) 411 (47.4) 456 (52.6) 374 (47.6) 412 (52.4)
OPV1 706 (75.5) 229 (24.5) 621 (73.8) 221 (26.2) 491 (55.7) 391 (44.3) 444 (55.7) 353 (44.3)
OPV2 619 (67.6) 297 (32.4) 537 (64.7) 293 (35.3) 404 (46.2) 471 (53.8) 360 (45.5) 432 (54.5)
OPV3 493 (54.7) 409 (45.3) 427 (52.7) 383 (47.3) 334 (38.3) 539 (61.7) 288 (36.6) 499 (63.4)
DPT1 567 (61.3) 358 (38.7) 513 (60.9) 329 (39.1) 344 (39.2) 534 (60.8) 327 (41.4) 463 (58.6)
DPT2 493 (54.1) 418 (45.9) 436 (52.8) 390 (47.2) 309 (35.4) 563 (64.6) 276 (35.1) 510 (64.9)
DPT3 466 (51.8) 434 (48.2) 398 (49.1) 412 (50.9) 278 (32.0) 590 (68.0) 240 (30.7) 543 (69.3)
Measles 419 (47.6) 462 (52.4) 367 (45.4) 441 (54.6) 231 (27.5) 610 (72.5) 190 (25.3) 561 (74.7)
The following tests assess the differences between sexes for the uptake of each vaccine.
Pearson's Chi-Square Significance, SNP Pearson's Chi-Square Significance, FHP
BCG p=0.238 DPT1 p=0.873 BCG p=0.942 DPT1 p=0.358
OPV1 p=0.396 DPT2 p=0.578 OPV1 p=0.987 DPT2 p=0.891
OPV2 p=0.204 DPT3 p=0.275 OPV2 p=0.769 DPT3 p=0.547
OPV3 p=0.421 Measles p=0.379 OPV3 p=0.484 Measles p=0.328
1994 SNP, ALL Districts, n (%) 1997 FHP, ALL Districts, n (%)
Vaccine Males Females Males Females
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In order to more accurately assess immunization coverage, complete and age-appropriate
immunization status was assessed for children over 12 months, and birth through nine
months, respectively. A summary of complete immunization coverage is presented in
Table 4.4.
Table 4.4 Complete Immunization Coverage by Sex
Males (555) Females (482) Males (605) Females (536)
Complete 320 (57.7) 260 (53.9) 190 (31.4) 148 (27.6)
Incomplete 235 (42.3) 222 (46.1) 415 (68.6) 388 (72.4)
Vaccine Status 1994 SNP, All Districts, n (%) 1997 FHP, All Districts, n (%)
Chi-Square=1.961 df=1 p=0.161Chi-Square=1.445 df=1 p=0.229
Although fewer females have attained the status of being completely immunized,
immunization coverage is similar among males and females within each dataset. Neither
SNP nor FHP show statistically significant differences among sex (p>0.05).
Interestingly, complete immunization coverage is shown to have decreased from 1994 to
1997 (57.7% to 31.4% in males and 53.9% to 27.6% in females).
A similar analysis for age-appropriate immunization is presented in Table 4.5.
Table 4.5 Age-Appropriate Immunization Coverage by Sex
Males (212) Females (213) Males (239) Females (232)
Age-appropriate 74 (34.9) 90 (42.3) 23 (9.6) 40 (17.2)
Not up-to-date 138 (65.1) 123 (57.7) 216 (90.4) 192 (82.8)
Vaccine Status 1994 SNP, All Districts, n (%) 1997 FHP, All Districts, n (%)
Chi-Square=2.421 df=1 p=0.120 Chi-Square=5.896 df=1 p=0.015
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As there are fewer children in the younger age category, the lower samples here reflect
that. Unlike the complete immunization coverage, this age-appropriate coverage
indicates that more females are up-to-date on their immunizations than their male
counterparts. This trend is visible in both the SNP and FHP datasets. This finding,
while not significant in 1994 (p>0.05) is statistically significant within the 1997 FHP
data (p<0.05).
In the 1994 SNP data, a statistically significant difference was found in complete
immunization status between districts (p<0.001) (Table 4.6). The number of children
categorized as being completely immunized was higher than those categorized as
incomplete in the districts of Badin (66.7%) and Mirpur Khas (73.6%); the reverse is
observed in Thatta (40.8%) and Tharparkar (43.2%).
The same data revealed no statistically significant difference in age-appropriate
immunization status across districts (p>0.05). Age-appropriate immunization uptake
ranged from 30.3% in Thatta to 45.9% in Tharparkar. Interestingly, Tharparkar, which
holds one of the lowest levels of complete immunization, also boasts the highest levels
of age-appropriate immunization. Results are presented in Table 4.6.
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Table 4.6 Immunization Status by District, 1994 SNP Survey
Complete Incomplete Yes No
Thatta (415) 106 (40.8) 154 (59.2) 27 (30.3) 62 (69.7)
Tharparkar (522) 114 (43.2) 150 (56.8) 51 (45.9) 60 (54.1)
Badin (480) 170 (66.7) 85 (33.3) 41 (37.6) 68 (62.4)
Mirpur Khas (460) 190 (73.6) 68 (26.4) 45 (38.8) 71 (61.2)
*Immunization Status for children 12-36 months
**Age-appropriate status for children up to and including 9 months
Immunization Status* n (%) Age-Appropriate Immunization** n (%)District (n)
Chi-Square=86.421 df=3 p<0.001 Chi-Square=5.138 df=3 p=0.162
The FHP data show similar trends (Table 4.7). A statistically significant difference was
found when comparing complete immunization status across districts (p<0.01), while the
age-appropriate immunization status only revealed borderline significance across
districts (p<0.10). In this data, however, the number of children categorized as having
complete immunization was lower than those categorized as incomplete in each of the
four districts; the same trend is evident in age-appropriate status (see Table 4.7).
Table 4.7 Immunization Status by District, 1997 FHP Survey
Complete Incomplete Yes No
Thatta (449) 111 (37.4) 186 (62.6) 25 (20.3) 98 (79.7)
Tharparkar (412) 31 (13.2) 204 (86.8) 16 (10.5) 119 (89.5)
Badin (429) 118 (33.1) 238 (66.9) 6 (9.8) 55 (90.2)
Mirpur Khas (404) 78 (30.8) 175 (69.2) 16 (11.9) 119 (88.1)
*Immunization Status for children 12-36 months
**Age-appropriate status for children up to and including 9 months
District (n) Immunization Status* n (%) Age-Appropriate Immunization** n (%)
Chi-Square=41.289 df=3 p<0.001 Chi-Square=7.122 df=3 p=0.068
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Thatta, which has the highest levels of complete uptake (37.4%), also has the highest
levels of age-appropriate immunization (20.3%). Although Badin shows high levels of
complete uptake (33.1%), the same district has the lowest age-appropriate uptake
(9.8%).
When examining complete immunization uptake from 1994 (Table 4.6) to 1997 (Table
4.7), some unexpected results reveal themselves. In each of the four districts, complete
uptake is shown to have decreased across study years. The decrease ranges from as little
as 3.4% in Thatta, to as much as 42.8% in Mirpur Khas. Age-appropriate uptake shows
a similar decline from 1994 to 1997. Age-appropriate status in children is shown to have
decreased by 10.0% in Thatta, 35.4% in Tharparkar, 27.8% in Badin, and 26.9% in
Mirpur Khas.
4.3 Research Objective 2: Correlates of Complete and Age-Appropriate
Immunization in 1997
A bivariate analysis was conducted to assess the individual effect of each independent
variable on immunization status. In this analysis, using complete immunization status as
the outcome variable, many independent variables were found to be statistically
significant at p<0.20 (Table 4.8). The odds of complete immunization were 0.162 in
females, compared to males. Also, the odds of complete immunization were less for
those who did not own a radio, TV, refrigerator, washing machine (etc.) than in those
who did own one or more of the above.
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The bivariate analysis of age-appropriate immunization status also revealed many
independent correlates (p<0.20), including: sex of the child, knowledge and use of
contraception, district of residence, as well as a number of SES indicators (Table 4.9).
As in the FHP dataset, many of the statistically significant variables represent socio-
economic status of the child’s family.
There was some concern that using too many measures of SES in the multivariable
modeling would result in inappropriate results. A series of cross-tabulations was
therefore done for each pair of independent variables (e.g. radio and TV, radio and
refrigerator, TV and refrigerator, etc.). Pearson’s chi-square was used to assess any
similarities between variables. Each of the tests revealed statistically significant
differences (p<0.01) between the variables. As a result, each independent variable that
was demonstrated to have a statistically significant effect (p<0.20) on the outcome
variable in the bivariate analysis was included in the full regression analysis.
Child’s sex, use of contraception, health district of residence, and an array of SES
indicators were therefore included in the multivariable modeling of complete
immunization.
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Table 4.8 Bivariate Analysis for Complete Immunization (ages 12 to 36 months)
Lower Upper
Child's sex Male 190 (16.6) 415 (36.4) 1
Female 148 (13.0) 388 (34.0) 0.162
Deaths last 5 years Yes 41 (3.6) 94 (8.2) 1
No 297 (26.0) 709 (62.2) 0.960
Where Seek Health Care Gov't 137 (12.1) 305 (27.0) 1
Private Clinic 201 (17.9) 485 (43.0) 0.923
Radio Yes 128 (11.3) 183 (16.0) 1
No 210 (18.4) 620 (54.3) 0.484
TV Yes 84 (7.4) 78 (6.8) 1
No 254 (22.3) 725 (63.5) 0.325
Refrigerator Yes 41 (3.6) 14 (1.2) 1
No 297 (26.0) 789 (69.2) 0.129
Washing Machine Yes 32 (2.8) 7 (0.6) 1
No 306 (26.8) 796 (69.8) 0.084
Water Pump No 42 (3.7) 15 (1.3) 1
Yes 296 (25.9) 788 (69.1) 0.134
Air Conditioner Yes 14 (1.2) 1 (0.1) 1
No 324 (28.4) 802 (70.3) 0.029
Motorcycle Yes 25 (2.2) 22 (1.9) 1
No 313 (27.4) 781 (68.5) 0.353
Car/van Yes 25 (2.2) 21 (1.8) 1
No 313 (27.4) 782 (68.6) 0.336
Electricity Yes 187 (16.4) 271 (23.8) 1
No 151 (13.2) 532 (46.6) 0.411
Bicycle Yes 49 (4.3) 47 (4.1) 1
No 289 (25.3) 756 (66.3) 0.367
LHW Visit Yes 82 (7.2) 92 (8.1) 1
No 256 (22.4) 711 (62.3) 0.404
Overcrowding No 99 (9.2) 186 (17.3) 1
Yes 223 (20.7) 567 (52.8) 0.739
House Type Pucca 118 (10.3) 133 (11.7) 1
Kucha 220 (19.3) 670 (58.7) 0.370
Heard of Contraception Yes 202 (17.7) 470 (41.2) 1
No 136 (11.9) 333 (29.2) 0.950
Use Contraception Yes 51 (4.5) 72 (6.3) 1
No 287 (25.2) 730 (64.0) 0.555
Health District Thatta 111 (9.7) 186 (16.3) 1 - - <0.001*
Tharparkar 31 (2.7) 204 (17.9) 0.255 0.163 0.397 <0.001*
Badin 118 (10.3) 238 (20.9) 0.831 0.602 1.147 0.260
Mirpur Khas 78 (6.8) 175 (15.3) 0.747 0.523 1.066 0.108*
*p<0.20
0.734 1.231 0.699
0.378 0.815 0.003*
0.554 0.986 0.04*
0.277 0.495 <0.001*
0.240 0.559 <0.001*
0.290 0.562 <0.001*
0.185 0.609 <0.001*
0.317 0.533 <0.001*
0.004 0.220 0.001*
0.196 0.635 0.001*
0.037 0.193 <0.001*
0.073 0.246 <0.001*
0.232 0.457 <0.001*
0.069 0.239 <0.001*
0.650 1.420 0.840
0.368 0.637 <0.001*
Incomplete
n (%)
0.645 1.076 0.162*
Independent Variable p-valueCompleten (%) Unadj. OR
95% CI for β
0.711 1.197 0.544
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Table 4.9 Bivariate Analysis for Age-Appropriate Immunization (ages birth to 9 months)
Lower Upper
Child's sex Male 23 (4.8) 216 (45.9) 1
Female 40 (8.5) 192 (40.8) 1.957
Deaths last 5 years Yes 9 (1.9) 51 (10.8) 1
No 54 (11.5) 357 (75.8) 0.857
Where Seek Health Care Gov't 36 (7.7) 182 (39.3) 1
Private Clinic 27 (5.8) 218 (47.1) 0.626
Radio Yes 22 (4.7) 96 (20.4) 1
No 41 (8.7) 312 (66.2) 0.573
TV Yes 12 (2.5) 35 (7.5) 1
No 51 (10.8) 373 (79.2) 0.399
Refrigerator Yes 9 (1.9) 6 (1.3) 1
No 54 (11.4) 402 (85.4) 0.090
Washing Machine Yes 7 (1.5) 5 (1.0) 1
No 56 (11.9) 403 (85.6) 0.099
Water Pump No 5 (1.1) 6 (1.2) 1
Yes 58 (12.3) 402 (85.4) 0.173
Air Conditioner Yes 1 (0.2) 1 (0.2) 1
No 62 (13.2) 407 (86.4) 0.152
Motorcycle Yes 4 (0.8) 12 (2.6) 1
No 59 (12.5) 396 (84.1) 0.447
Car/van Yes 3 (0.6) 9 (1.9) 1
No 60 (12.7) 399 (84.8) 0.451
Electricity Yes 29 (6.1) 152 (32.3) 1
No 34 (7.2) 256 (54.4) 0.696
Bicycle Yes 5 (1.1) 28 (5.9) 1
No 58 (12.3) 380 (80.7) 0.855
LHW Visit Yes 15 (3.2) 63 (13.4) 1
No 48 (10.2) 345 (73.2) 0.584
Overcrowding No 14 (3.2) 96 (21.6) 1
Yes 48 (10.8) 286 (64.4) 1.151
House Type Pucca 14 (3.0) 67 (14.2) 1
Kucha 49 (10.4) 341 (72.4) 0.688
Heard of Contraception Yes 29 (6.2) 236 (50.1) 1
No 34 (7.2) 172 (36.5) 1.609
Use Contraception Yes 10 (2.1) 34 (7.2) 1
No 53 (11.3) 374 (79.4) 0.482
Health District Thatta 25 (5.3) 98 (20.8) 1 - - 0.075*
Tharparkar 16 (3.4) 136 (28.9) 0.461 0.234 0.909 0.026*
Badin 6 (1.3) 55 (11.7) 0.428 0.165 1.106 0.080*
Mirpur Khas 16 (3.4) 119 (25.3) 0.527 0.266 1.043 0.066*
*p<0.20
0.944 2.741 0.080*
0.225 1.032 0.060*
0.608 2.180 0.666
0.359 1.316 0.258
0.317 2.302 0.756
0.308 1.107 0.099*
0.119 1.713 0.242
0.408 1.188 0.184*
0.009 2.467 0.185*
0.140 1.432 0.175*
0.030 0.323 <0.001*
0.051 0.585 0.005*
0.195 0.818 0.012*
0.031 0.261 <0.001*
0.366 1.071 0.087*
0.326 1.010 0.054*
1.131 3.386 0.016*
0.399 1.841 0.693
Unadj. OR 95% CI for βNot Up-to-date n(%) p-valueIndependent Variable
Up-to-date
n(%)
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Using the statistically significant variables of the bivariate analysis (child’s sex, radio,
TV, refrigerator, washing machine, water pump, air conditioner, motorcycle, can/van,
electricity, LHW visit, overcrowding, house type, and health district), a logistic
regression model was created to assess the correlates of complete immunization status.
A forward regression method was used.ii Variables in the final model included those
with p<0.05. The main effects of the regression model for complete immunization are
presented in Table 4.10, below.
Table 4.10 Multivariable Model (Main Effects) for Complete Immunization (ages 12 to 36
months), n=1074
Lower Upper
CONSTANT 13.804 - - <0.001
Radio (yes) 0.713 0.507 1.002 0.051
Water Pump (no) 0.360 0.172 0.755 0.007*
Electricity (yes) 0.674 0.473 0.962 0.030*
Bicycle (yes) 0.570 0.353 0.918 0.021*
LHW Visit (yes) 0.489 0.315 0.759 0.001*
House Type (pucca) 0.637 0.437 0.930 0.020*
Health District (Thatta) <0.001*
Tharparkar 0.290 0.179 0.472 <0.001*
Badin 0.599 0.420 0.854 0.005*
Mirpur Khas 0.271 0.169 0.433 <0.001*
*p<0.05
Independent Variable
(reference) OR
95% CI for β p-value
Hosmer-Lemeshow Goodness of Fit: Chi-square = 5.746 df = 6 sig. = 0.452
ii Although a forward regression model was used, many regression methods (e.g. backward, enter) were tested; all yielded
similar results.
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In this model, not owning a radio or bicycle and not having electricity were indicative of
lower odds of complete immunization. Similarly, those who did not have a LHW visit
the home had decreased odds of complete immunization. Those children living in kucha
(temporary, not concrete) homes were also at decreased odds of being completely
immunized, compared to children living in pucca (permanent, concrete) homes.
Children in the Thatta district had the greatest odds (OR=1) of being completely
immunized.
The Hosmer and Lemeshow Goodness of Fit test yielded a significance of 0.452. Since
p>0.05, the null hypothesis was not rejected; this model is considered to adequately fit
the data.
A similar regression model was created using the statistically significant variables from
the bivariate analysis (child’s sex, where seek health care, radio, TV, refrigerator,
washing machine, water pump, air conditioner, motorcycle, electricity, LHW visit, heard
of contraception, use contraception, and health district) to explore the correlates of age-
appropriate immunization status. The main effects included: child’s sex, ownership of
refrigerator, and having heard of contraception (Table 4.11).
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Table 4.11 Multivariable Model (Main Effects) for Age-Appropriate Immunization (ages
birth to 9 months), n=463
Lower Upper
CONSTANT 0.892 - - 0.842
Child sex (male) 1.851 1.050 3.262 0.033*
Refrigerator (yes) 0.079 0.026 0.241 <0.001*
Heard of Contraception (yes) 1.925 1.090 3.401 0.024*
*p<0.05
Independent Variable
(reference) OR
95% CI for β p-value
Hosmer-Lemeshow Goodness of Fit: Chi-square = 1.041 df = 2 sig. = 0.594
Interestingly, these results reveal that the odds of females being up-to-date on their
immunization doses are 1.851 times the odds of males being up-to-date. Those children
who do not have a refrigerator in the house are at decreased odds of having age-
appropriate immunization. Finally, those children whose parents have not heard of
contraception are 1.925 increased odds of being immunized for their age, compared to
children whose parents have not heard of at least one form of contraception.
The Hosmer and Lemeshow Goodness of Fit test for the age-appropriate immunization
model had a significance of 0.594. As with the complete immunization model, since
p>0.05, the null hypothesis was not rejected and this model is therefore considered to fit
the data well.
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CHAPTER 5
DISCUSSION
The results presented in the previous chapter often coincide with the published literature
on correlates of immunization and expected immunization uptake. The following will
provide some insight into and explanation of these results.
5.1 Immunization Uptake in 1994 and 1997
The WHO keeps records of the percentage of children immunized. Coverage surveys
are conducted every few years, and country estimates fill in the gaps. According to their
own data, the country estimates show consistently higher estimates than the results of the
coverage survey, with the exception of OPV. In 2001, the estimates were as follows
(Table 5.1):
Table 5.1 WHO Estimates of Immunization Uptake in Pakistan, 2001
Vaccine Coverage Survey (%) Country Estimate (%) % Difference
BCG 67 93 -26
DPT1 71 86 -15
DPT3 63 76 -13
OPV3 89 74 15
MCV 57 75 -18
*Table created using WHO data (1).
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Keeping this in mind, an attempt may be made to compare WHO country estimates for
1997 with those presented in Chapter 4 of this thesis. According to the WHO (50), the
reported immunization coverage is as follows:
 BCG, 90%
 DPT3, 74%
 OPV3, 77%
 MCV, 74%
These results are much higher than those reported in Table 4.3. This study finds that
BCG uptake is 47.4% for males and 47.6% for females. Similarly, DPT3 is 32.0% for
males, 30.7% for females, OPV3 is 38.3% for males and 36.6% for females, and MCV
is 27.5% for males and 25.3% for females. So why is it that the results found here are in
no way comparable to those rates reported by the WHO? The answer here is remarkably
simple, although not immediately obvious. We are measuring two different things. In
this study, the aim was to report the crude immunization uptake levels. These values
represent the immunization status of all children surveyed. In the WHO reports,
however, the numbers reflect the percentage of targeted population that was immunized.
Each year, the WHO selects a target population which will receive immunization
coverage. The target population is not all children, and does not include all geographic
areas. The measures they report are therefore meant to reflect the success of their
immunization efforts for that particular year. Readers should take note of this difference
in reporting and be weary when making comparisons between this data and that of the
WHO.
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Turning now to the comparison of immunization uptake between study years (1994 and
1997); we see that the results show an overall decrease in coverage levels. Given the
immunization efforts of the WHO, it seems counterintuitive that coverage should drop.
The substantial decreases in complete and age-appropriate immunizations among males
and females (Tables 4.4 and 4.5) cannot be explained merely by the over- or
underestimation of individual immunization status alone. There are a number of
possible explanations for this observed decrease. First, we may speculate that there may
have been a change in funding for the EPI program in Pakistan. Although no evidence
of this has been found, any decrease in funding may have resulted in a corresponding
decrease in immunization coverage. Second, there may have been a change in the
targeted populations. As mentioned previously, the populations targeted by the WHO to
receive the year’s allotment of immunizations may change from year-to-year. It is
plausible that more immunization efforts were being supported in the areas of Thatta,
Tharparkar, Badin and Mirpur Khas in 1994 than in 1997. This may also explain why
some districts experienced greater decreases in immunization coverage than others
(Tables 4.6 and 4.7). A third and well-documented theory is the change in immunization
focus. The international health community expressed great concern when, in 1988 the
Global Polio Eradication Initiative was created (12). The declaration had good
intentions and sought only to eradicate the disease worldwide. Concerns arose, however,
from the idea that the OPV vaccine would take priority over other immunization efforts.
Health workers and researchers worried that the polio eradication efforts would therefore
hinder coverage of BCG, DPT and MCV (51). Pakistan joined the polio eradication
initiative in 1994. Coverage seems to have dropped between 1994 and 1997. The
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concern of the polio efforts overshadowing other immunization campaigns seems
unlikely in these regions, however, as polio coverage did not seem to increase. It, along
with BCG, DPT and MCV all dropped between study years (Table 4.3). While this
theory cannot be entirely discounted, we would expect to see higher levels of OPV
uptake in 1997 as the other immunization levels dropped.
5.2 Correlates of Immunization
Gender and markers of SES were the two main focuses in determining the correlates of
complete and age-appropriate immunization. The following is a review and discussion
of the results pertaining to these demographic variables and enabling factors.
5.2.1 The Gender Difference
The Expanded Programme on Immunization (EPI) in Pakistan has, without doubt,
contributed to an increase in immunization uptake in all children (52). It has often been
noted in the literature, however, that gender differences remain. Females, in general,
seem to be immunized less often than their male counterparts. One study focusing solely
on Pakistan notes that “substantial gender gaps remain only in rural Sindh” (52). This
same study found that females aged 12 to 23 months were less likely to receive DPT3
and BCG immunizations than males of the same age, and were significantly less likely
(p<0.05) to receive the recommended measles immunization (52).
This study collected immunization information on roughly equal numbers of males and
females (Figures 4.1 and 4.2). When looking at specific doses, no statistically significant
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differences were found in BCG, OPV, or DPT between genders (Table 4.3). This trend,
including children aged birth to 36 months, was apparent in both SNP and FHP datasets.
Unlike the study summarized above, however, there was no statistically significant
(p<0.05) difference in uptake of measles vaccine between genders in 1994 or 1997.
When exploring gender differences, it may be more appropriate to examine complete
and age-appropriate immunization coverage. The former, examining children aged 12 to
36 months, showed no statistically significant differences in either 1994 (p=0.229) or
1997 (p=0.161) (Table 4.4). The latter, aimed at evaluating the uptake of children aged
birth through nine months, only showed a statistically significant gender gap (p=0.015)
in the 1997 dataset (Table 4.5). The bivariate analysis of sex on immunization outcome
found females have lower odds of complete immunization (OR=0.162), but higher odds
of age-appropriate immunization (OR=1.957). The subsequent multivariable regression
analysis revealed that gender only played a role in the immunization of children less than
nine months (Table 4.11). In this case, females had higher odds of immunization
(OR=1.851) than their male counterparts.
If gender gaps are so often noted in the literature, why then does gender only play a role
in the early doses of immunization in Sindh, Pakistan? The answer may be explained, in
part, by the WHO’s support of the EPI.
Throughout the 1970s and 1980s, the EPI program was proven to be very effective in
increasing immunization to LDCs and reducing disease in those areas. As a result,
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additional resources were committed in the 1990s to step up the immunization efforts.
Special attention was being paid to eradicating polio. The EPI program went into the
villages in an effort to immunize all eligible children. The program does not
discriminate due to gender. Disease can affect anyone and, as such, both males and
females are given the doses appropriate to their age.
Since the EPI does not have a constant presence in any one village, children may be born
and not immediately immunized. The initial immunizations at birth are therefore often
the responsibility of the parents. As the EPI health workers return to the villages, all
unimmunized children receive the ‘catch-up’ doses they require. Females and males
return to more equal immunization levels, therefore offering a potential explanation to
the more similar coverage levels among the older children.
The higher observed levels of age-appropriate immunization in females is harder to
explain. Although most research seems to find that males are more likely to receive
medical treatment than females, the reverse trend is apparent in this study. It would be
interesting to see if this trend remains true for the treatment of ailments and disease in the
same rural area of Pakistan. Perhaps parents in these regions are coddling their female
children more than their male children – including seeking out certain medical
treatments. Maybe the results are somewhat artifactual and parents are more likely to
overestimate the recall of females being immunized than males. To discover the exact
reason, additional information not available here would be required.
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5.2.2 The Role of Socio-Economic Status as a Correlate of Immunization
The results presented in Chapter 4 are, for the most part, as expected when discussing the
effect of SES on immunization uptake. Previous research has shown that those families
who have a higher SES are more likely to have their children immunized than low-SES
families. In both the bivariate (Tables 4.8, 4.9) each regression analysis (Tables 4.10,
4.11), this was found to be true.
Why is it that families living in houses with fewer amenities, who have more irregular
contact with health workers, and who have apparently lower levels of education are also
those who are less likely to be immunizing their children? Again we turn to the EPI
program for an explanation of these results. The WHO recognizes that lower SES
families often have a greater difficulty in paying for transportation, health care fees and
child care when bringing one of their often many children to be immunized. Rural
residents have an even greater difficulty in traveling into town to seek such services.
The EPI program, however, cannot be deployed to each small rural village – this would
be costly and time-consuming. As a result, the lowest of low-SES families may be
continuing to receive poor immunization coverage. With this explanation, the regression
results from this study may be explained. Children aged 12 to 36 months were less
likely to be immunized (Table 4.10) if the family did not own a radio (OR=0.713), did
have a water pump (OR=0.360), did not have electricity (OR=0.674), did not own a
bicycle (OR=0.570), did not have a LHW visit the home (OR=0.489), living in a kucha
house (OR=0.637), or lived in the districts of Tharparkar (OR=0.290), Badin
(OR=0.599), or Mirpur Khas (OR=0.271).
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Younger children, between birth and nine months, were more likely to be immunized
(Table 4.11) if the child was female (OR=1.851), the family did own a refrigerator
(OR=1) and the mother had not heard of contraception (OR=1.925).
5.3 Exploring the Modified EPI Two-Stage Cluster Survey Sampling Method
This study employed the use of a stratified random sampling technique, with proportion
to population size (PPS) methods. This methodology for household selection is similar
to that of the EPI random walk method. Developed by the WHO in 1978 (22), notable
characteristics of the EPI method include:
 Selection of communities using PPS;
 Selection of households by interviewers in the field;
 Using a sample size of ‘30 x 7’ (30 clusters of seven children each);
 Not returning to non-response houses (53).
The WHO often refers to this methodology (also called the ‘two-stage cluster survey
technique’) when discussing the estimation of immunization coverage (21). Step one
of the data collection involves the random sampling of 30 clusters. Clusters may
represent geographic or political boundaries (22). Using PPS, clusters with larger
populations have a higher chance of selection. Step two of the two-stage technique sees
the selection of seven children for each of the 30 clusters. After randomly selecting the
first household, subsequent houses are visited based on proximity to the first.
Immunization data from the seven individuals is pooled to estimate coverage for that
cluster.
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While this method is one that has been used in numerous studies, it is not without its
faults. First, this method assumes that members within each cluster possess similar traits
and are therefore not entirely independent of one another (53). In making this
assumption, researchers may justify using only seven individuals to estimate coverage
for the cluster. This assumption may be inaccurate if the geographic region is large or
spread out. Second, in the event that there is a non-response (e.g. the home owners are
not at home when the researcher calls), the researchers do not return to the house at a
later time. This may lead to additional bias in the study, as non-responders may differ
from responders. Third, the researchers choose households in the field based on
proximity. Unconscious bias of the researcher may alter the route. Use of a sampling
frame would be preferred.
In an effort to reduce the inherent bias of this study, the researchers of this study decided
to modify the data collection methods. First, it was decided that PPS techniques would
be used to select households within each stratum. Larger villages would therefore mean
that more individuals were surveyed. Samples were not limited to seven children per
cluster. Second, researchers chose to return to homes in the event of a non-response.
Interviewers would return on two separate occasions in the attempt to reach the home
owners. Only after these attempts were proven to be unsuccessful did the researchers
give up. This was important in reducing bias. Finally, although the researchers were
keen on choosing households in a fair and unbiased way, sampling frames were not
available for all rural and remote villages. As a result, this portion of the data collection
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methodology remained unchanged from the original EPI random walk method.
While the 30 cluster technique is often used for estimating immunization coverage, and
is a valid method for collecting such information, the investigators of this study
recognized that certain geographic characteristics also made the two-stage cluster survey
an unrealistic choice. Most notably, this study was spread over a large population, living
in very diverse environments. Over four provinces, data from 18 districts was collected.
Each district was further divided into smaller villages. Individual villages differed in
local employment opportunities, religious and family beliefs, as well as environmental
factors. As each of these has the potential to affect immunization uptake, the
investigators found it necessary to evaluate uptake levels in as many villages as possible.
The 30 cluster technique, had it been used here, is not likely to have captured an accurate
picture of immunization uptake in the area. The clusters, when chosen at random, may
not have covered each district as thoroughly as was desired.
Finally, and most notably, the stratified random sampling technique with PPS was
chosen over the two-stage cluster survey technique because it was better suited to the
collection and analysis of correlates of immunization. The 30 x 7 cluster survey, while
useful in estimating immunization coverage, is not appropriate for the analysis of
correlates. The investigators of the 1994 SNP and 1997 FHP studies were quite keen on
measuring demographic variables and enabling factors and therefore decided that the
stratified sampling methods, which may be used to collect information on potential
correlates, was a better choice.
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In using this modified technique, the investigators were able to not only tailor the
methodology to better suit the study, but are also confident that in doing so, the inherent
bias of the study was reduced.
5.4 Study Limitations
As with all studies, this one has its limitations. First, in using previously collected data,
the statistical analyses done for this project was limited to the study variables collected in
the survey. The author of this thesis, for example, was interested in measuring the
immunization uptake and subsequently comparing that to incidence of disease in the
same area. Disease information, however, was unavailable, and thus the analyses of the
study were guided by which variables were available.
With respect to external validity, this study may not be generalized to a greater
population since the study population is unique. The participants of the surveys were all
rural residents. As research has shown differences in rural and urban populations, it
would be inappropriate to generalize these findings to urban areas of Pakistan.
Moreover, as this study was conducted in an LDC in which polio remains endemic,
generalization cannot be made to more developed countries where such diseases are not
viewed as problematic or where children are not immunized for these diseases.
When discussing the time frame of this study, it is important to note that since the data
was collected some years ago and the WHO has since put more stringent immunization
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measures into place since then, the results may not reflect the current state of childhood
immunizations in Sindh, Pakistan.
One important piece of information that has been lost in the study files over the years is
the question of response rate. While the primary investigator has indicated that response
rate for those who were successfully contacted was very good, exact numbers remain a
mystery, as does the answer to the question: how many households that were approached
participated in the survey (i.e. not simply those who were contacted successfully)?
Inherent in the cross-sectional study design is also recall bias and the inability to show
causality. As discussed earlier, parental recall on immunization status has been studied
in some depth. Despite the possibility of overestimation, parental recall is viewed as an
acceptable source of such information.
Despite the aforementioned shortcomings of this study, the investigators remain
confident that the information presented here is accurate and, at the very least,
representative of the state of immunization in Sindh in the 1990’s.
5.5 Future Directions
Vaccines have long been described as possibly “the greatest public health achievement
of the 20th century” (54). There is no doubt that research into immunization coverage
and efforts should continue. The author would therefore like to make some
recommendations to improve upon future studies.
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1. Future studies employing the use of survey data should make note of the
response rate. In presenting this data and reasons for non-response, a more
complete picture of the current uptake of immunization may be painted.
2. Collecting information about levels of disease. In this study, no
information about prevalence of disease was available. It would be
beneficial to compare immunization uptake by district to disease levels in
those same areas, as immunization areas with higher disease rates may be
potential targets for future EPI efforts. In making these comparisons,
policy changes may be recommended.
3. Continuing to collect immunization information as part of the EPI
program. It would be beneficial to continue to collect such information so
that a trend analysis may be done to compare uptake from year to year.
While it is important to analyze the success of the program by reporting
percentage of the targeted population immunized, it is equally important to
determine the percentage of the total population immunized.
4. Collecting additional information on population characteristics is
recommended. It would be interesting to see the effects of additional
family characteristics (e.g. family size, age and gender of primary
caregiver), enabling factors (e.g. income, education of caregiver), and
knowledge and attitudes on immunization status.
While the ideas listed above may be ambitious and costly, each would add another
dimension to the information currently available for Pakistan and would therefore
provide important information for policy makers concerned with international health and
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immunization efforts.
5.6 Conclusions
This study sought to: 1) explore the uptake of complete and age-appropriate
immunization across study years; and 2) determine the correlates of complete and age-
appropriate immunization.
It was found that immunization uptake of individual vaccines, complete and age-
appropriate immunization all decreased from 1994 to 1997. This trend was apparent
across genders and districts.
Although each of the study areas shows a decrease in immunization uptake from 1994 to
1997, residents of Mirpur Khas and Tharparkar show the greatest drop in complete and
age-appropriate immunization, respectively. This may be explained by the populations
chosen to be targeted for immunization as part of the EPI program. Caution is advised
when comparing these data to those of the WHO as the populations (i.e. the
denominators) are different.
In accord with expectations, high SES (as measured by an array of material possessions)
was a correlate of complete and age-appropriate immunization. District of residence was
important to the complete immunization regression model, while sex of the child was
only statistically significant in the age-appropriate model; females had higher odds of
immunization uptake than males.
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These results are expected to contribute to the growing body of literature on
immunization uptake and correlates of complete and age-appropriate immunization.
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Appendix A: Indicators of Health: A Comparison Between Pakistan and Canada
(2003)
Health Indicators Pakistan Canada
GDP (per capita) $1,920 $30,429
Life expectancy – Males 62.0 years 78.0 years
Life expectancy – Females 62.0 years 82.0 years
Child mortality – Males 98 per 100,000 6 per 100,000
Child mortality – Females 108 per 100,000 5 per 100,000
Adult mortality – Males 225 per 100,000 93 per 100,000
Adult mortality – Females 199 per 100,000 57 per 100,000
Dependency ratio 82 per 100 45 per 100
* Sources: World Health Organization (WHO) (55, 56).
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Appendix B: Polio Eradication Maps, 1988 and 2004
* Source: UNICEF. Immunization Plus: Eradicating Polio (57).
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Appendix C: 1994 School Nutrition Program (SNP) Survey
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Appendix D: 1997 Family Health Project (FHP) Survey
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Appendix E: University of Saskatchewan Ethics Letter
97
Appendix F: List of Variables Available in the 1997 FHP Dataset
I = independent variables used in analysis
D = dependent variables used in analysis
N/A = variables used for organization of data or for deriving variables
N/A fmain_ke Main Household ID#
I childage Age of Child in Months
I childsex Sex of Child
0 = male
1 = female
N/A Totfmem Total # Household Members
N/A Rooms # Rooms Used for Sleeping
I Death5 Any Household Deaths (past 5 years)
1 = yes
2 = no
3 = don’t know
I NEWelectricity* Household electricity
1= yes
2 = no
I Radio* Own Radio/Tape Recorder
0 = yes
1 = no
I Tv* Own a TV
0 = yes
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1 = no
I Refreg* Own a Refrigerator
0 = yes
1 = no
I Wmachine* Own a Washing Machine
0 = yes
1 = no
I Wpump* Own a Water Pump
1 = yes
2 = no
I Acondi* Own an Air Conditioner
0 = yes
1 = no
I Mbike* Own a Motorcycle
0 = yes
1 = no
I Car* Own a Car/Van
0 = yes
1 = no
I NEWbicycle* Own a Bicycle
1 = yes
2 = no
I NEWhoustpe* House Type
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1 = pucca
2 = kucha
I Visitchw* Does a LHW visit your house
0 = yes
1 = no
N/A NEWbcg* Has Child Received BCG
1 = yes
2 = no
N/A NEWpolio1* Has Child Received Polio #1
1 = yes
2 = no
N/A NEWpolio2* Has Child Received Polio #2
1 = yes
2 = no
N/A NEWpolio3* Has Child Received Polio #3
1 = yes
2 = no
N/A NEWdpt1* Has Child Received DPT #1
1 = yes
2 = no
N/A NEWdpt2* Has Child Received DPT #2
1 = yes
2 = no
100
N/A NEWdpt3* Has Child Received DPT #3
1 = yes
2 = no
N/A NEWmeasle* Has Child Received MCV
1 = yes
2 = no
D NEWimmstatus3** Complete Immunization Status (12-36 mo.)
0 = Incomplete
1 = Complete
D NEWimmstatus4** Age Appropriate Immunization (birth-9 mo.)
0 = Not Age Appropriate
1 = Age Appropriate
I NEWovercrowding** Overcrowding (>3 people/room)
0 = no
1 = yes
I NEWdivdist* Division District of Residence
1 = Thatta
2 = Tharparkar
3 = Badin
4 = Mirpur Khas
I HearCcontraception** Ever heard of at least one kind of
contraception
1 = yes
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2 = no
I UseContraception** Ever used/using at least one kind of
contraception
1 = yes
2 = no
I Seekheal_recoded* Where do you usually seek health care
1 = Government Facility (e.g. hospital)
2 = Private Clinic
* recoded into binary form
** derived variables
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